Researchers Choose Drugs for Major Alzheimer’s Trial

Scientists have selected the first drugs to be evaluated in a worldwide clinical study to determine whether Alzheimer’s disease can be prevented. The pioneering trial is expected to start by early 2013, and initially will test three promising drugs, each meant to target Alzheimer’s differently.

In people with inherited mutations that cause early-onset Alzheimer’s, the study will investigate whether the drugs can improve Alzheimer’s disease biomarkers and prevent the loss of cognitive function. For more information, click here to read the full release.